The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Liposomes as nanomedical devices
Open accessAbstract
Since their discovery in the 1960s, liposomes have been studied in depth, and they continue to constitute a field of intense research. Liposomes are valued for their biological and technological advantages, and are considered to be the most successful drug-carrier system known to date. Notable progress has been made, and several biomedical applications of liposomes are either in clinical trials, are about to be put on the market, or have already been approved for public use. In this review, we briefly analyze how the efficacy of liposomes depends on the nature of their components and their size, surface charge, and lipidic organization. Moreover, we discuss the influence of the physicochemical properties of liposomes on their interaction with cells, half-life, ability to enter tissues, and final fate in vivo. Finally, we describe some strategies developed to overcome limitations of the "first-generation" liposomes, and liposome-based drugs on the market and in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 1×
“manufacture preparation is the thin-film hydration or Bangham method.(21,22) Briefly, this method involves dis-”
MethodEngineering Flows in Small Devices: Microfluidics Toward a Lab-on-a-Chip
Stone, H. A., Stroock, A. D., & Ajdari, A. (2004) · Annual Review of Fluid Mechanics · doi:10.1146/annurev.fluid.36.050802.122124 · Cited by 3,666
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Szoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
Hope, M. J., Bally, M. B., Webb, G., & Cullis, P. R. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90521-8 · Cited by 2,076
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles
O'Neal, D. P., Hirsch, L. R., Halas, N. J., Payne, J. D., & West, J. L. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.02.004 · Cited by 1,849
Bangham, A. D., & Horne, R. W. (1964) · Journal of Molecular Biology · doi:10.1016/s0022-2836(64)80115-7 · Cited by 1,809
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
The emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Small-volume extrusion apparatus for preparation of large, unilamellar vesicles
MacDonald, R. C., MacDonald, R. I., Menco, B. P. M., Takeshita, K., Subbarao, N. K., & Hu, L.-R. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90295-j · Cited by 1,493
Poly(ethylene glycol) chemistry : biotechnical and biomedical applications
Harris, J. M. (1992) · Plenum Press eBooks · Cited by 1,426
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Single bilayer liposomes prepared without sonication
Batzri, S., & Korn, E. D. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90408-2 · Cited by 1,358
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
Gabizon, A., & Papahadjopoulos, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6949 · Cited by 1,131
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Etheridge, M. L., Campbell, S. A., Erdman, A. G., Haynes, C. L., Wolf, S. M., & McCullough, J. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.013 · Cited by 1,088 · cited 1×
“However, liposomes applied to medical use range between 50 and 450 nm.(3) Liposomes seem to be an almost ideal drug-carrier system, since their morphol-”
BackgroundDesign of Liposomes for Enhanced Local Release of Drugs by Hyperthermia
Yatvin, M. B., Weinstein, J. N., Dennis, W. H., & Blumenthal, R. (1978) · Science · doi:10.1126/science.364652 · Cited by 956
Pegylation: A Novel Process for Modifying Pharmacokinetics
Harris, J. M., Martin, N. E., & Modi, M. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00005 · Cited by 913
Nanoparticles in cellular drug delivery
Faraji, A. H., & Wipf, P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.043 · Cited by 903
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
Novel applications of liposomes
Lasic, D. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(98)01220-7 · Cited by 867
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R. H., Verbavatz, J. M., & Langer, R. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00026-4 · Cited by 820
Yeh, M.-K., Chang, H.-I., & Cheng, M.-Y. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26766 · Cited by 801
Evans, E., & Needham, D. (1987) · The Journal of Physical Chemistry · doi:10.1021/j100300a003 · Cited by 800
Al-Jamal, W. T., & Kostarelos, K. (2011) · Accounts of Chemical Research · doi:10.1021/ar200105p · Cited by 696
Preparation, Characterization and Applications of Liposomes: State of the Art
Laouini, A., Jaafar-Maalej, C., Limayem-Blouza, I., Sfar, S., Charcosset, C., & Fessi, H. (2012) · Journal of Colloid Science and Biotechnology · doi:10.1166/jcsb.2012.1020 · Cited by 692
Nanoliposomes and Their Applications in Food Nanotechnology
Reza Mozafari, M., Johnson, C., Hatziantoniou, S., & Demetzos, C. (2008) · Journal of Liposome Research · doi:10.1080/08982100802465941 · Cited by 685
Liposomes as immunological adjuvants
ALLISON, A. C., & GREGORIADIS, G. (1974) · Nature · doi:10.1038/252252a0 · Cited by 675
Batist, G., Ramakrishnan, G., Rao, C. S., Chandrasekharan, A., Gutheil, J., Guthrie, T., Shah, P., Khojasteh, A., Nair, M. K., Hoelzer, K., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1444 · Cited by 669
Liposome application: problems and prospects.
Barenholz, Y. (2001) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(00)00090-x · Cited by 659
Löfblom, J., Feldwisch, J., Tolmachev, V., Carlsson, J., Ståhl, S., & Frejd, F. Y. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.014 · Cited by 651
Preparation and Use of Liposomes as Models of Biological Membranes
Bangham, A. D., Hill, M. W., & Miller, N. G. A. (1974) · Methods in Membrane Biology · doi:10.1007/978-1-4615-7422-4_1 · Cited by 585
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers
Torchilin, V. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.026 · Cited by 583 · cited 1×
“147,148 pH-sensitive, redox potential-sensitive, temperature-sensitive, magnetic field-sensitive, and ultrasound-sensitive liposomes have been produced.”
BackgroundAndresen, T. L., Jensen, S. S., & Jørgensen, K. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.12.001 · Cited by 580
Needham, D., & Dewhirst, M. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00233-2 · Cited by 570
Ligand-targeted liposome design: challenges and fundamental considerations
Noble, G. T., Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgicer, B. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.09.007 · Cited by 542
Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes
Kirby, C., & Gregoriadis, G. (1984) · Nature Biotechnology · doi:10.1038/nbt1184-979 · Cited by 532
Polymer vesicles in vivo: correlations with PEG molecular weight
Photos, P. J., Bacakova, L., Discher, B., Bates, F. S., & Discher, D. E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00201-3 · Cited by 527
Dawidczyk, C. M., Kim, C., Park, J. H., Russell, L. M., Lee, K. H., Pomper, M. G., & Searson, P. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.036 · Cited by 527
Miller, C. R., Bondurant, B., McLean, S. D., McGovern, K. A., & O'Brien, D. F. (1998) · Biochemistry · doi:10.1021/bi980096y · Cited by 524
Large volume liposomes by an ether vaporization method
Deamer, D., & Bangham, A. D. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90483-1 · Cited by 521
Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin, O. M., Needham, D., & Dewhirst, M. W. (2000) · PubMed · Cited by 505
Dromi, S., Frenkel, V., Luk, A., Traughber, B., Angstadt, M., Bur, M., Poff, J., Xie, J., Libutti, S. K., Li, K. C. P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2443 · Cited by 492
On the formulation of pH-sensitive liposomes with long circulation times
Simões, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.038 · Cited by 483
Theranostic Nanomedicine for Cancer
Sumer, B., & Gao, J. (2008) · Nanomedicine · doi:10.2217/17435889.3.2.137 · Cited by 478
Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
Gabizon, A. A. (2001) · Cancer Investigation · doi:10.1081/cnv-100103136 · Cited by 458
Liposome Technology for Industrial Purposes
Wagner, A., & Vorauer-Uhl, K. (2011) · Journal of Drug Delivery · doi:10.1155/2011/591325 · Cited by 435
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.
Thurston, G., McLean, J. W., Rizen, M., Baluk, P., Haskell, A., Murphy, T. J., Hanahan, D., & McDonald, D. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci965 · Cited by 423
PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
Milla, P., Dosio, F., & Cattel, L. (2012) · Current Drug Metabolism · doi:10.2174/138920012798356934 · Cited by 419
Semple, S. C., Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00128-2 · Cited by 402
The effect of cholesterol on the structure of phosphatidylcholine bilayers
McIntosh, T. J. (1978) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(78)90110-4 · Cited by 395
Yarosh, D., Klein, J., O'Connor, A., Hawk, J., Rafal, E., & Wolf, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04214-8 · Cited by 390
Single bilayer vesicles prepared without sonication physico-chemical properties
Brunner, J., Skrabal, P., & Hausser, H. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90308-4 · Cited by 383
Imparting size, shape, and composition control of materials for nanomedicine
Euliss, L. E., DuPont, J. A., Gratton, S., & DeSimone, J. (2006) · Chemical Society Reviews · doi:10.1039/b600913c · Cited by 381
Drummond, D. C., Noble, C. O., Guo, Z., Hong, K., Park, J. W., & Kirpotin, D. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4007 · Cited by 380
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient
Mayer, L. D., Bally, M. B., & Cullis, P. R. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90105-7 · Cited by 379
Campbell, R. B., Fukumura, D., Brown, E. B., Mazzola, L. M., Izumi, Y., Jain, R. K., Torchilin, V. P., & Munn, L. L. (2002) · PubMed · Cited by 372
Gordon, A. N., Granai, C. O., Rose, P. G., Hainsworth, J., Lopez, A., Weissman, C., Rosales, R., & Sharpington, T. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3093 · Cited by 336
Zhang, J. A., Anyarambhatla, G., Ma, L., Ugwu, S., Xuan, T., Sardone, T., & Ahmad, I. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.06.009 · Cited by 334
Ishida, T., Harashima, H., & Kiwada, H. (2002) · Bioscience Reports · doi:10.1023/a:1020134521778 · Cited by 330
Moen, M. D., Lyseng-Williamson, K. A., & Scott, L. J. (2009) · Drugs · doi:10.2165/00003495-200969030-00010 · Cited by 321
Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels
Krasnici, S., Werner, A., Eichhorn, M. E., Schmitt‐Sody, M., Pahernik, S. A., Sauer, B., Schulze, B., Teifel, M., Michaelis, U., Naujoks, K., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11108 · Cited by 313
Thermosensitive polymer-modified liposomes
Kono, K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00204-6 · Cited by 303
Rafiyath, S. M., Rasul, M., Lee, B., Wei, G., Lamba, G., & Liu, D. (2012) · Experimental Hematology & Oncology · doi:10.1186/2162-3619-1-10 · Cited by 302
Aleku, M., Schulz, P., Keil, O., Santel, A., Schaeper, U., Dieckhoff, B., Janke, O., Endruschat, J., Durieux, B., Röder, N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2428 · Cited by 293
Stamatatos, L., Leventis, R., Zuckermann, M. J., & Silvius, J. R. (1988) · Biochemistry · doi:10.1021/bi00411a005 · Cited by 286
New, R. R. C. (1990) · Medical Entomology and Zoology · Cited by 286
Liposomen: Möglichkeiten der Medikamentenfreisetzung
Allen, T. M. (1997) · Drugs · doi:10.2165/00003495-199700544-00004 · Cited by 279
Pros and Cons of the Liposome Platform in Cancer Drug Targeting
Gabizon, A. A., Shmeeda, H., & Zalipsky, S. (2006) · Journal of Liposome Research · doi:10.1080/08982100600848769 · Cited by 272
Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots
Muthu, M. S., Kulkarni, S. A., Raju, A., & Feng, S.-S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.036 · Cited by 265
Protein and peptide drug delivery: Oral approaches
Shaji, J., & Patole, V (2008) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.42967 · Cited by 262
Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet.
Gabizón, A. (2001) · PubMed · Cited by 259
Berger, N., Sachse, A., Bender, J., Schubert, R., & Brandl, M. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00721-9 · Cited by 258
Drug delivery vehicles on a nano-engineering perspective
Felice, B., Prabhakaran, M. P., Rodríguez, A. P., & Ramakrishna, S. (2014) · Materials Science and Engineering: C · doi:10.1016/j.msec.2014.04.049 · Cited by 253
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes
Woodle, M. C., Matthay, K. K., Newman, M. S., Hidayat, J. E., Collins, L. R., Redemann, C., Martin, F. J., & Papahadjopoulos, D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90194-q · Cited by 241
Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting
Perche, F., & Torchilin, V. P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/705265 · Cited by 230
AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study
Ruozi, B., Belletti, D., Tombesi, A., Tosi, G., Bondioli, L., Forni, F., & Vandelli, M. A. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s14615 · Cited by 225
Lipid Polymorphisms and Membrane Shape
Frolov, V. A., Shnyrova, A. V., & Zimmerberg, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004747 · Cited by 225
Development and characterization of a novel liposome-based formulation of SN-38
Zhang, J. A., Xuan, T., Parmar, M., Ma, L., Ugwu, S., Ali, S., & Ahmad, I. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.10.015 · Cited by 220
Skin Toxic Effects of Polyethylene Glycol–Coated Liposomal Doxorubicin
Lotem, M., Hubert, A., Lyass, O., Goldenhersh, M. A., Ingber, A., Peretz, T., & Gabizon, A. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.12.1475 · Cited by 219
Cationic Liposomes Coated with Polyethylene Glycol As Carriers for Oligonucleotides
Meyer, O., Kirpotin, D., Hong, K., Sternberg, B., Park, J. W., Woodle, M. C., & Papahadjopoulos, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15621 · Cited by 215
Redox-Triggered Contents Release from Liposomes
Ong, W., Yang, Y., Cruciano, A. C., & McCarley, R. L. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8050469 · Cited by 214
Optimizing Combination Chemotherapy by Controlling Drug Ratios
Mayer, L. D., & Janoff, A. S. (2007) · Molecular Interventions · doi:10.1124/mi.7.4.8 · Cited by 214
Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia
Li, L., ten Hagen, T. L. M., Schipper, D., Wijnberg, T. M., van Rhoon, G. C., Eggermont, A. M. M., Lindner, L. H., & Koning, G. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.006 · Cited by 214
Niosomes as carriers for tretinoin. I. Preparation and properties
Manconi, M., Sinico, C., Valenti, D., Loy, G., & Fadda, A. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00971-1 · Cited by 211
Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211
Drug transport to brain with targeted liposomes
Schnyder, A., & Huwyler, J. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.99 · Cited by 210
Large volume liposomes by an ether vaporization method
Deamer, D., & Bangham, A. D. (1976) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(76)90527-x · Cited by 203
Fate of cationic liposomes and their complex with oligonucleotive in vivo
Litzinger, D. C., Brown, J. M., Wala, I., Kaufman, S. A., han, G. Y., Farrell, C. L., & Collins, D. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00268-5 · Cited by 201
HUANG, Z.-R., HUA, S.-C., YANG, Y.-L., & FANG, J.-Y. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00829.x · Cited by 200
Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice
McLean, J. W., Fox, E. A., Baluk, P., Bolton, P. B., Haskell, A., Pearlman, R., Thurston, G., Umemoto, E. Y., & McDonald, D. M. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.1.h387 · Cited by 199
Therapeutic Angiogenesis for Treating Cardiovascular Diseases
Deveza, L., Choi, J., & Yang, F. (2012) · Theranostics · doi:10.7150/thno.4419 · Cited by 192
Fahr, A., Hoogevest, P. V., May, S., Bergstrand, N., & S. Leigh, M. L. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.05.012 · Cited by 189
Poon, R. T., & Borys, N. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802677874 · Cited by 189
Light-Activated Content Release from Liposomes
Leung, S. J., & Romanowski, M. (2012) · Theranostics · doi:10.7150/thno.4847 · Cited by 189
Microfluidic Methods for Production of Liposomes
Yu, B., Lee, R. J., & Lee, L. J. (2009) · Methods in Enzymology · doi:10.1016/s0076-6879(09)65007-2 · Cited by 187
Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review
Lao, J., Madani, J., Puértolas, T., Álvarez, M., Hernández, A., Pazo-Cid, R., Artal, Á., & Antón Torres, A. (2013) · Journal of Drug Delivery · doi:10.1155/2013/456409 · Cited by 185
Gursel, I., Gursel, M., Ishii, K. J., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3324 · Cited by 182
Liposome–Nanoparticle Hybrids for Multimodal Diagnostic and Therapeutic Applications
Al-Jamal, W. T., & Kostarelos, K. (2007) · Nanomedicine · doi:10.2217/17435889.2.1.85 · Cited by 179
Moghimi, S. M., Hedeman, H., Muir, I. S., Illum, L., & Davis, S. S. (1993) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(93)90105-h · Cited by 176
Nanotheranostics – a review of recent publications
Ho, J. A., Wang, L., & Chuang, M.-C. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33065 · Cited by 174
Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide
Garg, A., Tisdale, A. W., Haidari, E. S., & Kokkoli, E. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.016 · Cited by 174
Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents
Zamboni, W. C. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0180 · Cited by 173
Theranostics: Are We There Yet?
Svenson, S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300644n · Cited by 169
Li, S., Goins, B., Zhang, L., & Bao, A. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300175d · Cited by 168
Pharmacokinetics of liposome-encapsulated anti-tumor drugs
Juliano, R. L., & Stamp, D. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90252-6 · Cited by 166
Papahadjopoulos, D., & Kimelberg, H. K. (1974) · Progress in Surface Science · doi:10.1016/s0079-6816(74)80006-7 · Cited by 161
Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
Allen, T. M., Mehra, T., Hansen, C., & Chin, Y. C. (1992) · PubMed · Cited by 159
Lipid−Quantum Dot Bilayer Vesicles Enhance Tumor Cell Uptake and Retention in Vitro and in Vivo
Al-Jamal, W. T., Al‐Jamal, K. T., Tian, B., Lacerda, L., Bomans, P. H. H., Frederik, P. M., & Kostarelos, K. (2008) · ACS Nano · doi:10.1021/nn700176a · Cited by 159
Hauck, M., LaRue, S. Μ., Petros, W. P., Poulson, J. M., Yu, D., Spasojević, I., Pruitt, A. F., Klein, A., Case, B. C., Thrall, D. Ε., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0226 · Cited by 158
Functional reconstitution of influenza virus envelopes.
Stegmann, T., Morselt, H. W. M., Booy, F. P., van Breemen, J. F., Scherphof, G. L., & Wilschut, J. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02556.x · Cited by 158
Interaction of positively-charged liposomes with blood: implications for their application in vivo
Senior, J. H., Trimble, K. R., & Maskiewicz, R. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90160-a · Cited by 157
Glück, R., Mischler, R., Brantschen, S., et al. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116141 · Cited by 156
Markman, M., KENNEDY, A. W., Webster, K. D., Peterson, G., Kulp, B., & Belinson, J. L. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5921 · Cited by 155
Modifications of the Acid-Base Status of the Internal Milieu of Tumors
Gullino, P. M., Grantham, F. H., Smith, S. H., & Haggerty, A. C. (1965) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/34.6.857 · Cited by 155
Integrin Targeting for Tumor Optical Imaging
Ye, Y., & Chen, X. S. (2011) · Theranostics · doi:10.7150/thno/v01p0102 · Cited by 154
Daemen, T., Hofstede, G., ten Kate, M. T., Bakker‐Woudenberg, I. A. J. M., & Scherphof, G. L. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610520 · Cited by 153
White, S. C., Lorigan, P. C., Margison, G. P., Margison, J. M., Martin, F., Thatcher, N., Anderson, H., & Ranson, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603345 · Cited by 152
Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y. M., Kubo, K., Nakagawa, S., Nakanishi, M., Tanaka, K., & Mayumi, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00097-8 · Cited by 149
Dragovich, T., Mendelson, D. S., Kurtin, S. E., Richardson, K., Hoff, D. D. V., & Hoos, A. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0235-4 · Cited by 142
Analytical methods for the control of liposomal delivery systems
Gómez‐Hens, A., & Fernández-Romero, J. M. (2005) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2005.07.006 · Cited by 141
Ruozi, B., Tosi, G., Forni, F., Fresta, M., & Vandelli, M. A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.01.020 · Cited by 140
Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials
Alberts, D. S., Muggia, F. M., Carmichael, J., Winer, E. P., Jahanzeb, M., Venook, A. P., Skubitz, K. M., Rivera, E., Sparano, J. A., DiBella, N. J., et al. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.010 · Cited by 139
Mross, K. B., Niemann, B., Massing, U., Drevs, J., Unger, C., Bhamra, R. K., & Swenson, C. E. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0825-y · Cited by 137
Bandak, S., Goren, D., Horowitz, A. T., Tzemach, D., & Gabizon, A. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199911000-00007 · Cited by 137
Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes
Qi, X., Zhao, Z., & zhuang, Z. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25399 · Cited by 137
Cholesterol – a biological compound as a building block in bionanotechnology
Hosta‐Rigau, L., Zhang, Y., Teo, B. M., Postma, A., & Städler, B. (2012) · Nanoscale · doi:10.1039/c2nr32923a · Cited by 131
Bao, A., Goins, B., Klipper, R. W., Negrete, G. R., & Phillips, W. T. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059535 · Cited by 128
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): Phase I study
Stathopoulos, G. P., Boulikas, T., Vougiouka, M., Deliconstantinos, G., Rigatos, S., Darli, E., Viliotou, V., & Stathopoulos, J. (2005) · Oncology Reports · doi:10.3892/or.13.4.589 · Cited by 128
Heyes, J. A., Hall, K., Tailor, V., Lenz, R., & MacLachlan, I. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.012 · Cited by 126
Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging
Fang, J., Wen, C.-J., Zhang, Z., Al-Suwayeh, & Yen, T. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29369 · Cited by 126
Korgel, B. A., van Zanten, J. H., & Monbouquette, H. G. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)78033-6 · Cited by 125
Mohan, A., Narayanan, S., Sethuraman, S., & Krishnan, U. M. (2014) · BioMed Research International · doi:10.1155/2014/424239 · Cited by 123
Cryoelectron microscopy of liposomes
Frederik, P. M., & Hubert, D. H. W. (2005) · Methods in Enzymology · doi:10.1016/s0076-6879(05)91024-0 · Cited by 121
Reducing Liposome Size with Ultrasound: Bimodal Size Distributions
Woodbury, D. J., Richardson, E. S., Grigg, A. W., Welling, R. D., & Knudson, B. H. (2006) · Journal of Liposome Research · doi:10.1080/08982100500528842 · Cited by 118
Nie, Y., Li, J., Ding, H. Y., Xie, L., Li, L., He, B., Wu, Y., & Gu, Z. (2012) · Theranostics · doi:10.7150/thno.4949 · Cited by 117
Gabizón, A., Tzemach, D., Gorin, J., Mak, L., Amitay, Y., Shmeeda, H., & Zalipsky, S. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1132-4 · Cited by 116
Storm, G., Roerdink, F. H., Steerenberg, P. A., de Jong, W. H., & Crommelin, D. J. A. (1987) · PubMed · Cited by 112
Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles
Zhigaltsev, I. V., Winters, G. C., Srinivasulu, M., Crawford, J. B., Wong, M., Amankwa, L. N., Waterhouse, D., Masin, D., Webb, M. S., Harasym, N. L., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.029 · Cited by 109
Liposome-Encapsulated Anticancer Drugs: Still Waiting for the Magic Bullet?
Fanciullino, R., & Ciccolini, J. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789712916 · Cited by 109
Gasselhuber, A., Dreher, M. R., Negussie, A. H., Wood, B. J., Rattay, F., & Haemmerich, D. (2010) · International Journal of Hyperthermia · doi:10.3109/02656731003623590 · Cited by 109
Phase I Study of Liposomal Vincristine
Gelmon, K. A., Tolcher, A., Diab, A. R., Bally, M. B., Embree, L., Hudon, N. J., Dedhar, C., Ayers, D., Eisen, A. F., Melosky, B., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.697 · Cited by 108
Host Microvasculature Influence on Tumor Vascular Morphology and Endothelial Gene Expression
Roberts, W. G., Delaat, J. L., Nagane, M., Huang, S., Cavenee, W. K., & Palade, G. E. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65668-4 · Cited by 108
Löhr, M. J., Haas, S., Bechstein, W. O., Bodoky, G., Cwiertka, K., Fischbach, W., Fölsch, U. R., Jäger, D., Osinsky, D., Prausová, J., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr379 · Cited by 108
Fighting Cancer: From the Bench to Bedside Using Second Generation Cationic Liposomal Therapeutics
Campbell, R. B., Ying, B., Kuesters, G. M., & Hemphill, R. L. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21458 · Cited by 107
Bedu-Addo, F. K., Tang, P. S., Xu, Y., & Huang, L. (1996) · Pharmaceutical Research · doi:10.1023/a:1016091314940 · Cited by 106
Microfluidic remote loading for rapid single-step liposomal drug preparation
Hood, R. R., Vreeland, W. N., & DeVoe, D. L. (2014) · Lab on a Chip · doi:10.1039/c4lc00390j · Cited by 106
Strieth, S., Eichhorn, M., Sauer, B., Schulze, B. G., Teifel, M., Michaelis, U., & Dellian, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20083 · Cited by 104
Afrin, F., Ravindran, R., Anam, K., Sundaram, G. M., Pal, S., & Ali, N. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6697-6706.2002 · Cited by 104
Liposomes as Immunological Adjuvants
ALLISON, A. C., & Gregoriadis, G. (1976) · Springer eBooks · doi:10.1007/978-3-642-81049-7_8 · Cited by 104
Forssen, E. A., Malé-Brune, R., Adler‐Moore, J., Lee, M. J., Schmidt, P. G., Krasieva, T. B., Shimizu, S., & Tromberg, B. J. (1996) · PubMed · Cited by 103
Current status of liposomal porphyrinoid photosensitizers
Skupin-Mrugalska, P., Piskorz, J., Gośliński, T. A., Mielcarek, J., Konopka, K., & Düzgüneş, N. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.04.003 · Cited by 103
Charged liposomes as carriers to enhance the permeation through the skin
González-Rodríguez, M. L., & Rabasco, A. M. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.574610 · Cited by 102
Drug encapsulation and release from multilamellar and unilamellar liposomes
Betageri, G. V., & Parsons, D. L. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90015-t · Cited by 101
Smith, B. J., Lyakhov, I. G., Loomis, K. H., Needle, D., Baxa, U., Yavlovich, A., Capala, J., Blumenthal, R. P., & Puri, A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.005 · Cited by 99
Kheirolomoom, A., Lai, C.-Y., Tam, S. M., Mahakian, L. M., Ingham, E. S., Watson, K. D., & Ferrara, K. W. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.019 · Cited by 99
The bilayer stabilizing role of sphingomyelin in the presence of cholesterol. A 31P NMR study
Cullis, P. R., & Hope, M. J. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90225-4 · Cited by 98
Vascular targeting of doxorubicin using cationic liposomes
Wu, J. H., Lee, A., Lu, Y., & Lee, R. J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.003 · Cited by 97
Johnston, M., Edwards, K., Karlsson, G., & Cullis, P. R. (2008) · Journal of Liposome Research · doi:10.1080/08982100802129372 · Cited by 94
Liposome retention in size exclusion chromatography
Ruysschaert, T., Marque, A., Duteyrat, J.-L., Lesieur, S., Winterhalter, M., & Fournier, D. D. (2005) · BMC Biotechnology · doi:10.1186/1472-6750-5-11 · Cited by 93
Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept
Bitounis, D., Fanciullino, R., Iliadis, A., & Ciccolini, J. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/738432 · Cited by 92
Rudin, C. M., Marshall, J. L., Huang, C. H., Kindler, H. L., Zhang, C., Kumar, D., Gokhale, P. C., Steinberg, J., Wanaski, S., Kasid, U. N., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0642 · Cited by 90
Magnetoliposomes as magnetic resonance imaging contrast agents
Soenen, S. J., Velde, G. V., Ketkar-Atre, A., Himmelreich, U., & Cuyper, M. D. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.122 · Cited by 89
Lipid Formulations of Amphotericin B
Tollemar, J. G., & Ringdén, O. T. H. (1995) · Drug Safety · doi:10.2165/00002018-199513040-00001 · Cited by 87
Paramagnetic Liposome Nanoparticles for Cellular and Tumour Imaging
Kamaly, N., & Miller, A. D. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11041759 · Cited by 85
Andreopoulou, E., Gaiotti, D., Kim, E., Downey, A., Mirchandani, D., Hamilton, A., Jacobs, A., Curtin, J. P., & Muggia, F. M. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl484 · Cited by 85
Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer
Pisano, C., Cecere, S. C., Napoli, M. D., Cavaliere, C., Tambaro, R., Facchini, G., Scaffa, C., Losito, S., Pizzolorusso, A., & Pignata, S. (2013) · Journal of Drug Delivery · doi:10.1155/2013/898146 · Cited by 80
Lu, C. S., Perez-Soler, R., Piperdi, B., Walsh, G. L., Swisher, S. G., Smythe, W. R., Shin, H. J. C., Ro, J. Y., Feng, L., Truong, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.802 · Cited by 79
Targeted Expression of BikDD Eradicates Pancreatic Tumors in Noninvasive Imaging Models
Xie, X., Xia, W., Li, Z., Kuo, H.-P., Liu, Y., Li, Z., Ding, Q., Zhang, S., Spohn, B., Yang, Y., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.009 · Cited by 77
Hamaguchi, T., Matsumura, Y., Nakanishi, Y., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Niki, H., Hosokawa, S., Tagawa, T., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02495.x · Cited by 74
Behr, J., Zimmermann, G., Baumgartner, R., Leuchte, H. H., Neurohr, C., Brand, P., Herpich, C., Sommerer, K., Seitz, J., Menges, G., et al. (2009) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0714 · Cited by 74
T4 endonuclease V: review and application to dermatology
Cafardi, J. A., & Elmets, C. A. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.6.829 · Cited by 72
Lopes, S. C. D. A., Novais, M. V. M., Teixeira, C. S., Sampaio, K. H., Pereira, M. T., Ferreira, L. A. M., Braga, F. C., & Oliveira, M. C. (2013) · BioMed Research International · doi:10.1155/2013/467147 · Cited by 70
Liposomal encapsulated anthracyclines: new therapeutic horizons
Muggia, F. M. (2001) · Current Oncology Reports · doi:10.1007/s11912-001-0016-5 · Cited by 68
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer
Booser, D. J., Esteva, F. J., Rivera, E., Valero, V., Esparza-Guerra, L., Priebe, W., & Hortobágyi, G. N. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0464-0 · Cited by 67
Wen, C.-J., Sung, C. T., Aljuffali, I. A., Huang, Y., & Fang, J. (2013) · Nanotechnology · doi:10.1088/0957-4484/24/32/325101 · Cited by 67
Powell, J. S., Nugent, D. J., HARRISON, J. A., Soni, A., Luk, A. Y., STASS, H., & Gorina, E. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02856.x · Cited by 62
Liposome sensing and monitoring by organic electrochemical transistors integrated in microfluidics
Tarabella, G., Balducci, A. G., Coppedé, N., Marasso, S. L., D’Angelo, P., Barbieri, S., Cocuzza, M., Colombo, P., Sonvico, F., Mosca, R., et al. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.12.018 · Cited by 62
The Treatment of Breast Cancer Using Liposome Technology
Brown, S., & Khan, D. R. (2012) · Journal of Drug Delivery · doi:10.1155/2012/212965 · Cited by 61
Cancer-Selective Targeting and Cytotoxicity by Liposomal-Coupled Lysosomal Saposin C Protein
Qi, X., Chu, Z., Mahller, Y. Y., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3285 · Cited by 59
Systemic Delivery of SapC-DOPS Has Antiangiogenic and Antitumor Effects Against Glioblastoma
Wojton, J., Chu, Z., Mathsyaraja, H., Meisen, W. H., Denton, N. L., Kwon, C.-H., Chow, L. M. L., Palascak, M. B., Franco, R. S., Bourdeau, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.114 · Cited by 55
Size distribution of liposomes by flow field-flow fractionation
Moon, M. H., & Giddings, J. C. (1993) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(93)80049-7 · Cited by 55
MRI-Guided Focused Ultrasound as a New Method of Drug Delivery
Thanou, M., & Gedroyc, W. (2013) · Journal of Drug Delivery · doi:10.1155/2013/616197 · Cited by 55
Lipoplatin Treatment in Lung and Breast Cancer
Fantini, M., Gianni, L., Santelmo, C., Drudi, F., Castellani, C., Affatato, A. A., Nicolini, M., & Ravaioli, A. (2010) · Chemotherapy Research and Practice · doi:10.1155/2011/125192 · Cited by 53
Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculature
Dass, C. R. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.08.010 · Cited by 52
A new application for liposomes in cancer therapy
Vingerhoeds, M. H., Haisma, H. J., van Muijen, M., et al. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80861-n · Cited by 51
Badiee, A., Jaafari, M. R., Khamesipour, A., Samiei, A., Soroush, D., Kheiri, M. T., Barkhordari, F., McMaster, W. R., & Mahboudi, F. (2009) · Experimental Parasitology · doi:10.1016/j.exppara.2008.12.015 · Cited by 48
Farhat, F., Temraz, S. N., Kattan, J. G., Ibrahim, K., Bitar, N., Haddad, N., Jalloul, R., Hatoum, H. A., Nsouli, G., & Shamseddine, A. I. (2011) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.08.005 · Cited by 48
Chow, T.-H., Lin, Y.-Y., Hwang, J., Wang, H.-E., Tseng, Y., Pang, V. F., Liu, R.-S., Lin, W., Yang, C., & Ting, G. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.063503 · Cited by 48
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Metadata
- Authors
- Bozzuto, G., & Molinari, A.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2015-02
- Volume
- 10
- Pages
- 975
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2051925512
- Cited by
- 2,261
- References
- 212
- FWCI
- 44.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.